168 related articles for article (PubMed ID: 37206044)
1. Integrated serum pharmacochemistry and metabolomics reveal potential effective components and mechanisms of Shengjiang Xiexin decoction in the treatment of
Cui Y; Zhang C; Zhang X; Yu X; Ma Y; Qin X; Ma Z
Heliyon; 2023 May; 9(5):e15602. PubMed ID: 37206044
[TBL] [Abstract][Full Text] [Related]
2. Shengjiang Xiexin decoction mitigates murine Clostridium difficile infection through modulation of the gut microbiota and bile acid metabolism.
Yu XH; Lv Z; Zhang CE; Gao Y; Li H; Ma XJ; Ma ZJ; Su JR; Huang LQ
J Ethnopharmacol; 2024 Feb; 320():117384. PubMed ID: 37925000
[TBL] [Abstract][Full Text] [Related]
3. Shengjiang Xiexin Decoction ameliorates antibiotic-associated diarrhea by altering the gut microbiota and intestinal metabolic homeostasis.
Zhang CE; Yu XH; Cui YT; Wang HJ; Chen X; Ma XJ; Li H; Su JR; Ma ZJ; Huang LQ
Phytomedicine; 2023 May; 113():154737. PubMed ID: 36905867
[TBL] [Abstract][Full Text] [Related]
4. A multistep approach for exploring quality markers of Shengjiang Xiexin decoction by integrating plasma pharmacochemistry-pharmacokinetics-pharmacology.
Guan H; Wang Q; Mei Y; Ran J; Zeng F; Cai H; Wang D; Yang S; Zhang M; Shi Y; Liao S; Li P
J Pharm Biomed Anal; 2024 Apr; 241():115999. PubMed ID: 38306867
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Shengjiang Xiexin decoction in prophylaxis of chemotherapy-related diarrhea in small cell lung cancer patients: study protocol for a multicenter randomized controlled trial.
Deng C; Lou Y; Gao Y; Deng B; Su F; Jia L
Trials; 2020 May; 21(1):370. PubMed ID: 32357899
[TBL] [Abstract][Full Text] [Related]
6. Shengjiang Xiexin Decoction Alters Pharmacokinetics of Irinotecan by Regulating Metabolic Enzymes and Transporters: A Multi-Target Therapy for Alleviating the Gastrointestinal Toxicity.
Guan HY; Li PF; Wang XM; Yue JJ; He Y; Luo XM; Su MF; Liao SG; Shi Y
Front Pharmacol; 2017; 8():769. PubMed ID: 29163158
[TBL] [Abstract][Full Text] [Related]
7. Preventive Effects of a Chinese Herbal Formula, Shengjiang Xiexin Decoction, on Irinotecan-Induced Delayed-Onset Diarrhea in Rats.
Deng C; Deng B; Jia L; Tan H; Zhang P; Liu S; Zhang Y; Song A; Pan L
Evid Based Complement Alternat Med; 2017; 2017():7350251. PubMed ID: 28167974
[TBL] [Abstract][Full Text] [Related]
8. Sanhuang xiexin decoction ameliorates secondary liver injury in DSS-induced colitis involve regulating inflammation and bile acid metabolism.
Li L; Wang Y; Zhao L; Ye G; Shi F; Li Y; Zou Y; Song X; Zhao X; Yin Z; Wu X; Li W; Tang H
J Ethnopharmacol; 2022 Dec; 299():115682. PubMed ID: 36058478
[TBL] [Abstract][Full Text] [Related]
9. Sanhuang Xiexin decoction ameliorates DSS-induced colitis in mice by regulating intestinal inflammation, intestinal barrier, and intestinal flora.
Wu X; Fu S; Jiang M; Wang J; Tang H; Fang C; Li W; Fu C
J Ethnopharmacol; 2022 Oct; 297():115537. PubMed ID: 35843414
[TBL] [Abstract][Full Text] [Related]
10. [Effect of Shengjiang Xiexin Decoction on the Repair of Damaged Rat Intestinal Mucosa after Irinotecan Chemotherapy].
Wang J; Jia LQ; Tan HY; Pan L; Yu LL; Deng B
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1236-43. PubMed ID: 26677677
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of the Mechanisms and Molecular Targets of
Xu M; Li Z; Yang L; Zhai W; Wei N; Zhang Q; Chao B; Huang S; Cui H
Biomed Res Int; 2020; 2020():5848497. PubMed ID: 32851081
[No Abstract] [Full Text] [Related]
12. Combined exploration of the mechanism of Sang Xing Decoction in the treatment of smoke-induced acute bronchitis from protein and metabolic levels.
Sun X; Ai L; Ran Y; Zhang Y; Zhang Q; Li Q; Cui Y; Sun L
Biomed Pharmacother; 2022 Aug; 152():113254. PubMed ID: 35691159
[TBL] [Abstract][Full Text] [Related]
13. Sanhuang Xiexin Decoction Ameliorates TNBC By Modulating JAK2-STAT3 and Lipid Metabolism.
Qi Y; Wu XJ; Shi JB; Shi XW; Zhao N; Xiong Y; Wang LP
Chin J Integr Med; 2023 Nov; ():. PubMed ID: 37930511
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of 14 active constituents of Shengjiang Xiexin decoction using ultrafast liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Peng G; Guan H; Wang X; Shi Y
Acta Pharm Sin B; 2017 Mar; 7(2):193-201. PubMed ID: 28303226
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the chemical constituents of Shengjiang Xiexin decoction by ultrahigh-performance liquid chromatography-quadrupole/orbitrap high-resolution mass spectrometry and the impact of 20 characteristic components on multidrug resistance-associated protein 2 in the vesicular transport assay.
Guan H; Li P; Wang Q; Zeng F; Wu J; Zhang F; Liao S; Shi Y
J Sep Sci; 2022 Sep; 45(18):3459-3479. PubMed ID: 35838583
[TBL] [Abstract][Full Text] [Related]
16. An integrated strategy to study the combination mechanisms of Bupleurum chinense DC and Paeonia lactiflora Pall for treating depression based on correlation analysis between serum chemical components profiles and endogenous metabolites profiles.
Chen C; Tian J; Gao X; Qin X; Du G; Zhou Y
J Ethnopharmacol; 2023 Apr; 305():116068. PubMed ID: 36574791
[TBL] [Abstract][Full Text] [Related]
17. Integrated serum pharmacochemistry and network pharmacological analysis used to explore possible anti-rheumatoid arthritis mechanisms of the Shentong-Zhuyu decoction.
Wang L; Pu X; Nie X; Wang D; Jiang H; Chen Y; Pang L; Wang S; Wang X; Xu Z; Fu C; Lin D; Zhang J
J Ethnopharmacol; 2021 Jun; 273():113988. PubMed ID: 33667569
[TBL] [Abstract][Full Text] [Related]
18.
Battaglioli EJ; Hale VL; Chen J; Jeraldo P; Ruiz-Mojica C; Schmidt BA; Rekdal VM; Till LM; Huq L; Smits SA; Moor WJ; Jones-Hall Y; Smyrk T; Khanna S; Pardi DS; Grover M; Patel R; Chia N; Nelson H; Sonnenburg JL; Farrugia G; Kashyap PC
Sci Transl Med; 2018 Oct; 10(464):. PubMed ID: 30355801
[TBL] [Abstract][Full Text] [Related]
19. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.
Zhang L; Dong D; Jiang C; Li Z; Wang X; Peng Y
Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005
[TBL] [Abstract][Full Text] [Related]
20. The current novel therapeutic regimens for
Gao Y; Li H; Yang H; Su J; Huang L
Crit Rev Microbiol; 2019; 45(5-6):729-742. PubMed ID: 31838936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
